Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).
Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.
A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
Aquaporin 2 is a water-specific channel protein that is expressed in KIDNEY COLLECTING DUCTS. The translocation of aquaporin 2 to the apical PLASMA MEMBRANE is regulated by VASOPRESSIN, and MUTATIONS in AQP2 have been implicated in a variety of kidney disorders including DIABETES INSIPIDUS.
A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).
Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS.
The ability of the kidney to excrete in the urine high concentrations of solutes from the blood plasma.
A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or AQUAPORIN-2; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.
A drive stemming from a physiological need for WATER.
A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.
Aquaporin 3 is an aquaglyceroporin that is expressed in the KIDNEY COLLECTING DUCTS and is constitutively localized at the basolateral MEMBRANE.
Aquaporin 6 is an aquaglyceroporin that is found primarily in KIDNEY COLLECTING DUCTS. AQP6 protein functions as an anion-selective channel.
Na-K-Cl transporter in the ASCENDING LIMB OF LOOP OF HENLE. It mediates active reabsorption of sodium chloride and is inhibited by LOOP DIURETICS such as FUROSEMIDE; and BUMETANIDE. Mutations in the gene encoding SLC12A1 are associated with a BARTTER SYNDROME.
The withholding of water in a structured experimental situation.
A group of disorders caused by defective salt reabsorption in the ascending LOOP OF HENLE. It is characterized by severe salt-wasting, HYPOKALEMIA; HYPERCALCIURIA; metabolic ALKALOSIS, and hyper-reninemic HYPERALDOSTERONISM without HYPERTENSION. There are several subtypes including ones due to mutations in the renal specific SODIUM-POTASSIUM-CHLORIDE SYMPORTERS.
Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).
Involuntary discharge of URINE during sleep at night after expected age of completed development of urinary control.
Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
A class of porins that allow the passage of WATER and other small molecules across CELL MEMBRANES.
The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
The consumption of liquids.
A subclass of symporters that specifically transport SODIUM CHLORIDE and/or POTASSIUM CHLORIDE across cellular membranes in a tightly coupled process.
Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces.
An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER.
A general state of sluggishness, listless, or uninterested, with being tired, and having difficulty concentrating and doing simple tasks. It may be related to DEPRESSION or DRUG ADDICTION.
Involuntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).
Neural tissue of the pituitary gland, also known as the neurohypophysis. It consists of the distal AXONS of neurons that produce VASOPRESSIN and OXYTOCIN in the SUPRAOPTIC NUCLEUS and the PARAVENTRICULAR NUCLEUS. These axons travel down through the MEDIAN EMINENCE, the hypothalamic infundibulum of the PITUITARY STALK, to the posterior lobe of the pituitary gland.
Excessive amount of sodium in the blood. (Dorland, 27th ed)
Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.
Straight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube (duct of Bellini) which opens on the summit of the papilla.
The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
Aquaporin 1 forms a water-specific channel that is constitutively expressed at the PLASMA MEMBRANE of ERYTHROCYTES and KIDNEY TUBULES, PROXIMAL. It provides these cells with a high permeability to WATER. In humans polymorphisms of this protein result in the Colton blood group antigen.
Carrier proteins for OXYTOCIN and VASOPRESSIN. They are polypeptides of about 10-kDa, synthesized in the HYPOTHALAMUS. Neurophysin I is associated with oxytocin and neurophysin II is associated with vasopressin in their respective precursors and during transportation down the axons to the neurohypophysis (PITUITARY GLAND, POSTERIOR).
A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed)
An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
The ratio of the density of a material to the density of some standard material, such as water or air, at a specified temperature.
Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.

Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. (1/160)

The autosomal dominant neurological syndrome of Huntington's disease has been modeled in transgenic mice by the expression of a portion of the human huntingtin gene together with 140 CAG repeats (the R6/2 strain). The mice develop progressive chorea with onset at approximately 9 weeks of age and with death at approximately 13 weeks. Associated symptoms include weight loss and polyuria in the absence of eating or drinking deficits. We have found that these mice have insulin-responsive diabetes. Fasting glucose was 211 + 19 mg/dl in R6/2 mice compared with 93 + 5 mg/dl in C57/B6 controls (n = 12, both groups; P < 0.01). Administration of insulin intraperitoneally led to a reduction in blood glucose. At 12.5 weeks, animals were killed and pancreas weighed and analyzed for insulin and glucagon. Pancreatic mass in R6/2 mice was the same as controls, and islets appeared normal in morphology without lymphocytic infiltration. Immunohistochemical staining showed dramatic reductions in glucagon in the alpha-cells and in insulin in the beta-cells. Direct tissue assays showed glucagon and insulin content were reduced to only 10 and 15% of controls, respectively. Diabetes has been reported as being more common in Huntington's disease and other triplet repeat disorders. The R6/2 mouse should prove useful for elucidating the mechanism of diabetes in these genetic diseases.  (+info)

Dose related growth response to indometacin in Gitelman syndrome. (2/160)

Growth failure is a recognised feature of Gitelman syndrome, although it is not as frequent as in Bartter syndrome. Indometacin is reported to improve growth in Bartter syndrome, but not in Gitelman syndrome, where magnesium supplements are recommended. This paper presents 3 sisters with Gitelman syndrome who could not tolerate magnesium supplements, and whose hypotension and polyuria were eliminated by taking 2 mg/kg/day indometacin, but who grew poorly. However, increasing the indometacin dose to 4 mg/kg/day improved their growth significantly, without changing their symptoms or biochemistry. Gastrointestinal haemorrhage necessitated the use of misoprostol.  (+info)

Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats. (3/160)

A reduction of renal kallikrein has been found in non-insulin-treated diabetic individuals, suggesting that an impaired renal kallikrein-kinin system (KKS) contributes to the development of diabetic nephropathy. We analyzed relevant components of the renal KKS in non-insulin-treated streptozotocin (STZ)-induced diabetic rats. Twelve weeks after a single injection of STZ, rats were normotensive and displayed hyperglycemia, polyuria, proteinuria, and reduced glomerular filtration rate. Blood bradykinin (BK) levels and prekallikrein activity were significantly increased compared with controls. Renal kallikrein activity was reduced by 70%, whereas urinary BK levels were increased up to threefold. Renal kininases were decreased as indicated by a 3-fold reduction in renal angiotensin-converting enzyme activity and a 1.8-fold reduction in renal expression of neutral endopeptidase 24.11. Renal cortical expression of kininogen and B2 receptors was enhanced to 1.4 and 1. 8-fold, respectively. Our data suggest that increased urinary BK levels found in severely hyperglycemic STZ-diabetic rats are related to increased filtration of components of the plasma KKS and/or renal kininogen synthesis in combination with decreased renal kinin-degrading activity. Thus, despite reduced renal kallikrein synthesis, renal KKS is activated in the advanced stage of diabetic nephropathy.  (+info)

Analysis of the vasopressin system and water regulation in genetically polydipsic mice. (4/160)

Polydipsic mice, STR/N, which show extreme polydipsia and polyuria, were discovered in 1958. In the STR/N, urine outputs are much higher than in control mice. The possibility of an abnormal regulation of the arginine vasopressin (AVP) system, or an abnormality in the renal susceptibility to AVP, should be considered. In this study we investigated the AVP system and water regulation in STR/N. We sequenced the AVP and the AVP V(2)-receptor genes of the STR/N by direct sequencing. No mutation was found in either of them. AVP gene expression examined by in situ hybridization and plasma sodium in 8-wk-old STR/N was significantly lower than in control mice, whereas it was significantly higher at 20 wk. Renal sensitivity to injected AVP was attenuated in 20-wk-old STR/N. The suppression of AVP synthesis due to excessive water retention in 8-wk-old STR/N suggests that polydipsia may be the primary cause in this strain. The 20-wk-old STR/N became dehydrated with the acceleration of AVP synthesis, which might have resulted from secondary desensitization to AVP.  (+info)

Uncompensated polyuria in a mouse model of Bartter's syndrome. (5/160)

We have used homologous recombination to disrupt the mouse gene coding for the NaK2Cl cotransporter (NKCC2) expressed in kidney epithelial cells of the thick ascending limb and macula densa. This gene is one of several that when mutated causes Bartter's syndrome in humans, a syndrome characterized by severe polyuria and electrolyte imbalance. Homozygous NKCC2-/- pups were born in expected numbers and appeared normal. However, by day 1 they showed signs of extracellular volume depletion (hematocrit 51%; wild type 37%). They subsequently failed to thrive. By day 7, they were small and markedly dehydrated and exhibited renal insufficiency, high plasma potassium, metabolic acidosis, hydronephrosis of varying severity, and high plasma renin concentrations. None survived to weaning. Treatment of -/- pups with indomethacin from day 1 prevented growth retardation and 10% treated for 3 weeks survived, although as adults they exhibited severe polyuria (10 ml/day), extreme hydronephrosis, low plasma potassium, high blood pH, hypercalciuria, and proteinuria. Wild-type mice treated with furosemide, an inhibitor of NaK2Cl cotransporters, have a phenotype similar to the indomethacin-rescued -/- adults except that hydronephrosis was mild. The polyuria, hypercalciuria, and proteinuria of the -/- adults and furosemide-treated wild-type mice were unresponsive to inhibitors of the renin angiotensin system, vasopressin, and further indomethacin. Thus absence of NKCC2 in the mouse causes polyuria that is not compensated elsewhere in the nephron. The NKCC2 mutant animals should be valuable for uncovering new pathophysiologic and therapeutic aspects of genetic disturbances in water and electrolyte recovery by the kidney.  (+info)

Downregulation of aquaporin-2 and -3 in aging kidney is independent of V(2) vasopressin receptor. (6/160)

The mechanisms underlying age-related polyuria were investigated in 10- and 30-mo-old female WAG/Rij rats. Urinary volume and osmolality were 3.9 +/- 0.3 ml/24 h and 2,511 +/- 54 mosmol/kgH(2)O in adult rats and 12.8 +/- 0.8 ml/24 h and 1,042 +/- 44 mosmol/kgH(2)O in senescent animals. Vasopressin V(2) receptor mRNA did not significantly differ between 10 and 30 mo, and [(3)H]vasopressin binding sites in membrane papilla were reduced by 30%. The cAMP content of the papilla was unchanged with age, whereas papillary osmolality was significantly lowered in senescent animals. The expression of aquaporin-1 (AQP1) and -4 was mostly unaltered from 10 to 30 mo. In contrast, aquaporin-2 (AQP2) and -3 (AQP3) expression was downregulated by 80 and 50%, respectively, and AQP2 was markedly redistributed into the intracellular compartment, in inner medulla of senescent animals, but not in renal cortex. These results indicate that age-related polyuria is associated with a downregulation of AQP2 and AQP3 expression in the medullary collecting duct, which is independent of vasopressin-mediated cAMP accumulation.  (+info)

The mechanism of acute renal failure after uranyl nitrate. (7/160)

Administration of 25 mg/kg uranyl nitrate (UN) to rats leads to a brief period of polyuria followed by progressive oliguria with death at 5 days. Factors that determine glomerular filtration rate (GFR) were examined in control Munich-Wistar rats (n equals 16) and 2 h after either 15 mg/kg (n equals 8) or 25 mg/kg (n equals 7) of UN (i.v.) utilizing direct measurements of hydrostatic and oncotic pressures and plasma flow. Total kidney GFR was reduced to 47% of control in the low dose group and to 21% in the high dose group. The simultaneous nephron filtration rate (sngfr) was 28.6 plus or minus 0.8 nl/min/g kidney wt in control, 29.1 plus or minus 1.0 in the low dose group, and 18.1 plus or minus 1.2 (P less than 0.001) in the higher dose group. This disparity in UN effect upon GFR and sngfr was due to tubular back-diffusion of solute through damaged epithelia beyond the early proximal tubule as demonstrated by microinjection of inulin and mannitol in the proximal tubule. Inulin "leak" persisted at 6 h after UN when tubular pressure had returned to normal. Comparison of sngfr measured in early vs. late proximal tubule revealed no difference after high dose UN, suggesting no significant leak of inulin from the early proximal tubule, and that the decreased sngfr was due to primary reductions in ultrafiltration. Nephron plasma flow was equal to control at both doses of UN. Also directly measured hydrostatic pressure gradient across the glomerular capillary was not changed. The effective filtration pressure achieved equilibrium in control of animals but became significantly positive at the efferent end of the capillary at both doses of UN and increased. Total glomerular permeability (LpA) was progressively reduced from control (0.089 plus or minus 0.005 nl/s/g kidney wt/mm Hg) at low dose UN (0.047 plus or minus 0.013) and high dose 0.024 plus or minus 0.003 nl/s/g kidney wt/mm Hg). Therefore UN decreases GFR by two mechanisms: (1) tubular damage leading to back-diffusion of solutes and (b) a primary reduction in sngfr due to reduced LpA.  (+info)

The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. (8/160)

BACKGROUND: Taurine, which is the major intracellular free beta-amino acid, is known to be an endogenous antioxidant and a membrane-stabilizing agent. In this study, we wished to know whether taurine altered the concentration of gentamicin in kidney tissue and could protect against gentamicin-induced acute proximal tubular injury. METHODS: Wistar albino rats of both sexes were assigned to three groups, which all received one of the following daily intraperitoneal injections for 8 days: (i) 0.9% sodium chloride (NaCl) alone at the same volume as gentamicin treated rats (group C; n=8); (ii) 100 mg/kg/day gentamicin alone (group G; n=8, four male, four female); or (iii) 100 mg/kg/day gentamicin plus 7.5 ml/kg/day taurine (group G+T; n=9, five male, four female). Urine was collected for 24 h for the determination of urine volume and creatinine. Intracardiac blood was collected for blood urea nitrogen (BUN) and serum creatinine determination. The kidneys were removed, weighed, and the left kidneys were subjected to biochemical analysis for the determination of thiobarbituric acid-reactive substance (TBARS) and lactate levels, and glutathione peroxidase (Gpx) and superoxide dismutase (SOD) activities. The right kidneys were divided vertically in half. The upper halves were used for histopathological examination, by light and electron microscopy. The lower halves were used to detect the gentamicin concentration within the kidney tissue, by high-performance liquid chromatography (HPLC). Changes in body weight and normalized kidney weight were recorded. RESULTS: Taurine treatment reduced gentamicin-induced increases in serum creatinine, 24 h urine volume, BUN and tissue lactate and TBARS levels (0.57+/-0.02 vs 1.06+/-0.08 mg/dl, P<0.001; 9.00+/-1.46 vs 20.9+/-2.73 ml, P<0.001; 25.3+/-1.87 vs 54.1+/-6.99 mg/dl, P<0. 001; 2.56+/-0.10 vs 3.44+/-0.08 micromol/g wet tissue, P<0.001; and 66.4+/-3.41 vs 79.5+/-5.07 nmol/g wet tissue, P>0.05, respectively). Taurine reduced the accumulation of gentamicin within the kidney tissue (233+/-29 vs 494+/-93 microg/g wet tissue, P<0.05). Taurine treatment also prevented body weight loss due to gentamicin administration (17.8+/-1.64 vs -10.0+/-7.08 g, P<0.01) and normalized reduced Gpx and SOD activities (3.46+/-0.16 vs 2.37+/-0. 15 U/g wet tissue, P<0.01; and 15577+/-377 vs 12662+/-577 U/g wet tissue, P<0.01, respectively). Light microscopic examination of the renal tissues from gentamicin-treated rats revealed severe histopathological changes, whereas specimens obtained from taurine-treated rats revealed only mild changes. This finding was supported by electron microscopic examination. CONCLUSIONS: Our observations suggest that taurine treatment attenuates the accumulation of gentamicin within kidney tissue and counteracts the deleterious effect of gentamicin on renal tubular function. They may have potentially important clinical implications.  (+info)

Polyuria is a medical term that describes the production of large volumes of urine, typically defined as exceeding 2.5-3 liters per day in adults. This condition can lead to frequent urination, sometimes as often as every one to two hours, and often worsens during the night (nocturia). Polyuria is often a symptom of an underlying medical disorder such as diabetes mellitus or diabetes insipidus, rather than a disease itself. Other potential causes include kidney diseases, heart failure, liver cirrhosis, and certain medications. Proper diagnosis and treatment of the underlying condition are essential to manage polyuria effectively.

Polydipsia is a medical term that describes excessive thirst or an abnormally increased desire to drink fluids. It is often associated with conditions that cause increased fluid loss, such as diabetes insipidus and diabetes mellitus, as well as certain psychiatric disorders that can lead to excessive water intake. Polydipsia should not be confused with simple dehydration, where the body's overall water content is reduced due to inadequate fluid intake or excessive fluid loss. Instead, polydipsia refers to a persistent and strong drive to drink fluids, even when the body is adequately hydrated. Prolonged polydipsia can lead to complications such as hyponatremia (low sodium levels in the blood) and may indicate an underlying medical issue that requires further evaluation and treatment.

Diabetes Insipidus is a medical condition characterized by the excretion of large amounts of dilute urine (polyuria) and increased thirst (polydipsia). It is caused by a deficiency in the hormone vasopressin (also known as antidiuretic hormone or ADH), which regulates the body's water balance.

In normal physiology, vasopressin is released from the posterior pituitary gland in response to an increase in osmolality of the blood or a decrease in blood volume. This causes the kidneys to retain water and concentrate the urine. In Diabetes Insipidus, there is either a lack of vasopressin production (central diabetes insipidus) or a decreased response to vasopressin by the kidneys (nephrogenic diabetes insipidus).

Central Diabetes Insipidus can be caused by damage to the hypothalamus or pituitary gland, such as from tumors, trauma, or surgery. Nephrogenic Diabetes Insipidus can be caused by genetic factors, kidney disease, or certain medications that interfere with the action of vasopressin on the kidneys.

Treatment for Diabetes Insipidus depends on the underlying cause. In central diabetes insipidus, desmopressin, a synthetic analogue of vasopressin, can be administered to replace the missing hormone. In nephrogenic diabetes insipidus, treatment may involve addressing the underlying kidney disease or adjusting medications that interfere with vasopressin action. It is important for individuals with Diabetes Insipidus to maintain adequate hydration and monitor their fluid intake and urine output.

Aquaporin 2 (AQP2) is a type of aquaporin, which is a water channel protein found in the membranes of cells. Specifically, AQP2 is located in the principal cells of the collecting ducts in the kidneys. It plays a crucial role in regulating water reabsorption and urine concentration by facilitating the movement of water across the cell membrane in response to the hormone vasopressin (also known as antidiuretic hormone). When vasopressin binds to receptors on the cell surface, it triggers a cascade of intracellular signals that lead to the translocation of AQP2 water channels from intracellular vesicles to the apical membrane. This increases the permeability of the apical membrane to water, allowing for efficient reabsorption of water and concentration of urine. Dysfunction in AQP2 has been implicated in various kidney disorders, such as nephrogenic diabetes insipidus.

Neurogenic diabetes insipidus is a condition characterized by the production of large amounts of dilute urine (polyuria) and increased thirst (polydipsia) due to deficiency of antidiuretic hormone (ADH), also known as vasopressin, which is produced by the hypothalamus and stored in the posterior pituitary gland.

Neurogenic diabetes insipidus can occur when there is damage to the hypothalamus or pituitary gland, leading to a decrease in ADH production or release. Causes of neurogenic diabetes insipidus include brain tumors, head trauma, surgery, meningitis, encephalitis, and autoimmune disorders.

In this condition, the kidneys are unable to reabsorb water from the urine due to the lack of ADH, resulting in the production of large volumes of dilute urine. This can lead to dehydration, electrolyte imbalances, and other complications if not properly managed. Treatment typically involves replacing the missing ADH with a synthetic hormone called desmopressin, which can be administered as a nasal spray, oral tablet, or injection.

Antidiuretic agents are medications or substances that reduce the amount of urine produced by the body. They do this by increasing the reabsorption of water in the kidneys, which leads to a decrease in the excretion of water and solutes in the urine. This can help to prevent dehydration and maintain fluid balance in the body.

The most commonly used antidiuretic agent is desmopressin, which works by mimicking the action of a natural hormone called vasopressin (also known as antidiuretic hormone or ADH). Vasopressin is produced by the pituitary gland and helps to regulate water balance in the body. When the body's fluid levels are low, vasopressin is released into the bloodstream, where it causes the kidneys to reabsorb more water and produce less urine.

Antidiuretic agents may be used to treat a variety of medical conditions, including diabetes insipidus (a rare disorder that causes excessive thirst and urination), bedwetting in children, and certain types of headaches. They may also be used to manage fluid balance in patients with kidney disease or heart failure.

It is important to use antidiuretic agents only under the supervision of a healthcare provider, as they can have side effects and may interact with other medications. Overuse or misuse of these drugs can lead to water retention, hyponatremia (low sodium levels in the blood), and other serious complications.

Kidney concentrating ability refers to the capacity of the kidneys to increase the concentration of solutes, such as urea and minerals, and remove waste products while reabsorbing water to maintain fluid balance in the body. This is primarily regulated by the hormone vasopressin (ADH), which signals the collecting ducts in the nephrons of the kidneys to absorb more water, resulting in the production of concentrated urine. A decreased kidney concentrating ability may indicate a variety of renal disorders or diseases, such as diabetes insipidus or chronic kidney disease.

Nephrogenic diabetes insipidus is a type of diabetes insipidus that occurs due to the inability of the kidneys to respond to the antidiuretic hormone (ADH), also known as vasopressin. This results in excessive thirst and the production of large amounts of dilute urine.

In nephrogenic diabetes insipidus, the problem lies in the kidney tubules, which fail to absorb water from the urine due to a defect in the receptors or channels that respond to ADH. This can be caused by genetic factors, certain medications, kidney diseases, and electrolyte imbalances.

Treatment for nephrogenic diabetes insipidus typically involves addressing the underlying cause, if possible, as well as managing symptoms through a low-salt diet, increased fluid intake, and medications that increase water reabsorption in the kidneys.

Thirst, also known as dry mouth or polydipsia, is a physiological need or desire to drink fluids to maintain fluid balance and hydration in the body. It is primarily regulated by the hypothalamus in response to changes in osmolality and volume of bodily fluids, particularly blood. Thirst can be triggered by various factors such as dehydration, excessive sweating, diarrhea, vomiting, fever, burns, certain medications, and medical conditions affecting the kidneys, adrenal glands, or other organs. It is a vital homeostatic mechanism to ensure adequate hydration and proper functioning of various bodily systems.

Desmopressin, also known as 1-deamino-8-D-arginine vasopressin (dDAVP), is a synthetic analogue of the natural hormone arginine vasopressin. It is commonly used in medical practice for the treatment of diabetes insipidus, a condition characterized by excessive thirst and urination due to lack of antidiuretic hormone (ADH).

Desmopressin works by binding to V2 receptors in the kidney, which leads to increased water reabsorption and reduced urine production. It also has some effect on V1 receptors, leading to vasoconstriction and increased blood pressure. However, its primary use is for its antidiuretic effects.

In addition to its use in diabetes insipidus, desmopressin may also be used to treat bleeding disorders such as hemophilia and von Willebrand disease, as it can help to promote platelet aggregation and reduce bleeding times. It is available in various forms, including nasal sprays, injectable solutions, and oral tablets or dissolvable films.

Aquaporin 3 (AQP3) is a type of aquaglyceroporin, which is a subclass of aquaporins - water channel proteins that facilitate the transport of water and small solutes across biological membranes. AQP3 is primarily expressed in the epithelial cells of various tissues, including the skin, kidneys, and gastrointestinal tract.

In the skin, AQP3 plays a crucial role in maintaining skin hydration by facilitating water transport across the cell membrane. It also transports small neutral solutes like glycerol and urea, which contribute to skin moisturization and elasticity. In addition, AQP3 has been implicated in several physiological processes, such as wound healing, epidermal proliferation, and cutaneous sensory perception.

In the kidneys, AQP3 is involved in water reabsorption in the collecting ducts, helping to regulate body fluid homeostasis. In the gastrointestinal tract, it facilitates water absorption and secretion, contributing to maintaining proper hydration and electrolyte balance. Dysregulation of AQP3 has been associated with various pathological conditions, such as skin disorders, kidney diseases, and cancer.

Aquaporin 6 (AQP6) is a protein that functions as a water channel in the membranes of certain cells. It is a member of the aquaporin family, which are proteins that allow the selective transport of water and small solutes across biological membranes. Aquaporin 6 is primarily expressed in the kidney, where it is localized to the intracellular vesicles of intercalated cells in the collecting ducts. It is thought to play a role in acid-base balance and urine concentration by regulating the movement of water and hydrogen ions (protons) across cell membranes. Aquaporin 6 has also been found to be permeable to anions, making it unique among aquaporins. Additionally, AQP6 has been identified in other tissues such as the brain, lung, and testis, but its function in these tissues is not well understood.

Solute Carrier Family 12, Member 1 (SLC12A1) is a protein that functions as a sodium-potassium-chloride cotransporter (NKCC1). It is responsible for the transport of sodium, potassium, and chloride ions across the membrane of cells. This transporter plays a crucial role in regulating the volume and composition of fluids in various tissues, including the inner ear and brain. Dysfunction of this protein has been implicated in several medical conditions, such as hearing loss, balance disorders, and neurological disorders.

Water deprivation is a condition that occurs when an individual is deliberately or unintentionally not given access to adequate water for a prolonged period. This can lead to dehydration, which is the excessive loss of body water and electrolytes. In severe cases, water deprivation can result in serious health complications, including seizures, kidney damage, brain damage, coma, and even death. It's important to note that water is essential for many bodily functions, including maintaining blood pressure, regulating body temperature, and removing waste products from the body. Therefore, it's crucial to stay hydrated by drinking an adequate amount of water each day.

Bartter syndrome is a rare genetic disorder that affects the kidneys' ability to reabsorb sodium and chloride, leading to an imbalance of electrolytes in the body. This condition is characterized by hypokalemia (low potassium levels), metabolic alkalosis (high pH levels in the blood), and normal or low blood pressure. It can also result in increased urine production, excessive thirst, and growth retardation in children. There are two major types of Bartter syndrome, based on the genes affected: type I caused by mutations in the SLC12A1 gene, and type II caused by mutations in the KCNJ1 gene. Type III is caused by mutations in the CLCNKB gene, while type IV is caused by mutations in the BSND or CLCNKB genes. Treatment typically involves supplementation of electrolytes, such as potassium and magnesium, as well as nonsteroidal anti-inflammatory drugs (NSAIDs) to help reduce sodium loss in the urine.

Nocturia is a common symptom characterized by the need to wake up during the night one or more times to urinate. While it's normal to urinate a few times during the night, nocturia is defined as having to urinate more than twice per night, which can disrupt sleep and lead to daytime fatigue and sleepiness.

Nocturia can be caused by various factors, including underlying medical conditions such as diabetes, bladder infections, enlarged prostate, or sleep disorders like sleep apnea. It can also be a side effect of certain medications. In some cases, nocturia may be a symptom of more serious conditions, so it's important to speak with a healthcare provider if you experience frequent nighttime urination.

Nocturnal enuresis, also known as bedwetting, is a medical condition where an individual, usually a child, urinates involuntarily during sleep. It is considered to be a disorder when it occurs in children over the age of 5 years old, and is more common in boys than girls. Nocturnal enuresis can have various causes, including delayed development of bladder control, small bladder capacity, sleep disorders, urinary tract infections, structural or neurological abnormalities, and family history. Treatment options may include behavioral interventions, such as bladder training and fluid restriction, medications, or a combination of both.

Vasopressin, also known as antidiuretic hormone (ADH), is a hormone that helps regulate water balance in the body. It is produced by the hypothalamus and stored in the posterior pituitary gland. When the body is dehydrated or experiencing low blood pressure, vasopressin is released into the bloodstream, where it causes the kidneys to decrease the amount of urine they produce and helps to constrict blood vessels, thereby increasing blood pressure. This helps to maintain adequate fluid volume in the body and ensure that vital organs receive an adequate supply of oxygen-rich blood. In addition to its role in water balance and blood pressure regulation, vasopressin also plays a role in social behaviors such as pair bonding and trust.

Aquaporins are a type of membrane protein that function as water channels, allowing the selective and efficient transport of water molecules across biological membranes. They play crucial roles in maintaining fluid homeostasis, regulating cell volume, and supporting various physiological processes in the body. In humans, there are 13 different aquaporin subtypes (AQP0 to AQP12) that have been identified, each with distinct tissue expression patterns and functions. Some aquaporins also facilitate the transport of small solutes such as glycerol and urea. Dysfunction or misregulation of aquaporins has been implicated in several pathological conditions, including neurological disorders, cancer, and water balance-related diseases.

Arginine vasopressin (AVP), also known as antidiuretic hormone (ADH), is a hormone produced in the hypothalamus and stored in the posterior pituitary gland. It plays a crucial role in regulating water balance and blood pressure in the body.

AVP acts on the kidneys to promote water reabsorption, which helps maintain adequate fluid volume and osmotic balance in the body. It also constricts blood vessels, increasing peripheral vascular resistance and thereby helping to maintain blood pressure. Additionally, AVP has been shown to have effects on cognitive function, mood regulation, and pain perception.

Deficiencies or excesses of AVP can lead to a range of medical conditions, including diabetes insipidus (characterized by excessive thirst and urination), hyponatremia (low sodium levels in the blood), and syndrome of inappropriate antidiuretic hormone secretion (SIADH).

The term "drinking" is commonly used to refer to the consumption of beverages, but in a medical context, it usually refers to the consumption of alcoholic drinks. According to the Merriam-Webster Medical Dictionary, "drinking" is defined as:

1. The act or habit of swallowing liquid (such as water, juice, or alcohol)
2. The ingestion of alcoholic beverages

It's important to note that while moderate drinking may not pose significant health risks for some individuals, excessive or binge drinking can lead to a range of negative health consequences, including addiction, liver disease, heart disease, and increased risk of injury or violence.

Sodium-Potassium-Chloride Symporters are membrane transport proteins that facilitate the active transport of sodium, potassium, and chloride ions across the cell membrane. These symporters use the energy derived from the concentration gradient of sodium ions to co-transport potassium and chloride ions into or out of the cell. This process helps maintain electrolyte balance, regulate cell volume, and facilitate various physiological functions such as nerve impulse transmission and kidney function. An example of a Sodium-Potassium-Chloride Symporter is the NKCC1 (Na-K-2Cl cotransporter).

"Renal agents" is not a standardized medical term with a single, widely accepted definition. However, in a general sense, renal agents could refer to medications or substances that have an effect on the kidneys or renal function. This can include drugs that are primarily used to treat kidney diseases or disorders (such as certain types of diuretics, ACE inhibitors, or ARBs), as well as chemicals or toxins that can negatively impact renal function if they are not properly eliminated from the body.

It's worth noting that the term "renal agent" is not commonly used in medical literature or clinical practice, and its meaning may vary depending on the context in which it is used. If you have any specific questions about a particular medication or substance and its effect on renal function, I would recommend consulting with a healthcare professional for more accurate information.

The kidney medulla is the inner portion of the renal pyramids in the kidney, consisting of multiple conical structures found within the kidney. It is composed of loops of Henle and collecting ducts responsible for concentrating urine by reabsorbing water and producing a hyperosmotic environment. The kidney medulla has a unique blood supply and is divided into an inner and outer zone, with the inner zone having a higher osmolarity than the outer zone. This region of the kidney helps regulate electrolyte and fluid balance in the body.

Lithium is not a medical term per se, but it is a chemical element with symbol Li and atomic number 3. In the field of medicine, lithium is most commonly referred to as a medication, specifically as "lithium carbonate" or "lithium citrate," which are used primarily to treat bipolar disorder. These medications work by stabilizing mood and reducing the severity and frequency of manic episodes.

Lithium is a naturally occurring substance, and it is an alkali metal. In its elemental form, lithium is highly reactive and flammable. However, when combined with carbonate or citrate ions to form lithium salts, it becomes more stable and safe for medical use.

It's important to note that lithium levels in the body must be closely monitored while taking this medication because too much lithium can lead to toxicity, causing symptoms such as tremors, nausea, diarrhea, and in severe cases, seizures, coma, or even death. Regular blood tests are necessary to ensure that lithium levels remain within the therapeutic range.

Lethargy is a state of extreme fatigue, drowsiness, and/or lack of energy. In a medical context, lethargy may refer to a reduced level of consciousness or awareness where an individual has difficulty staying awake or responding to stimuli. It can be a symptom of various medical conditions such as infections, neurological disorders, metabolic imbalances, or psychological issues. However, it is important to note that lethargy should be evaluated by a healthcare professional for proper diagnosis and treatment.

Enuresis is a medical term that refers to the involuntary or unconscious release of urine, especially at night during sleep, in children who are at least 5 years old. It's commonly known as bedwetting. Enuresis can be classified into two types: primary and secondary. Primary enuresis occurs when a child has never achieved consistent dryness during sleep, while secondary enuresis happens when a child starts wetting the bed again after having been dry for at least six months.

Enuresis can have various causes, including developmental delays, small bladder capacity, urinary tract infections, constipation, sleep disorders, and emotional stress. In some cases, it may also be associated with genetic factors. Treatment options depend on the underlying cause and may include behavioral interventions, bladder training, alarm systems, medication, or a combination of these approaches.

The posterior pituitary gland, also known as the neurohypophysis, is the posterior portion of the pituitary gland. It is primarily composed of nerve fibers that originate from the hypothalamus, a region of the brain. These nerve fibers release two important hormones: oxytocin and vasopressin (also known as antidiuretic hormone or ADH).

Oxytocin plays a role in social bonding, sexual reproduction, and childbirth. During childbirth, it stimulates uterine contractions to help facilitate delivery, and after birth, it helps to trigger the release of milk from the mother's breasts during breastfeeding.

Vasopressin, on the other hand, helps regulate water balance in the body by controlling the amount of water that is excreted by the kidneys. It does this by increasing the reabsorption of water in the collecting ducts of the kidney, which leads to a more concentrated urine and helps prevent dehydration.

Overall, the posterior pituitary gland plays a critical role in maintaining fluid balance, social bonding, and reproduction.

Hypernatremia is a medical condition characterized by an abnormally high concentration of sodium (na+) in the blood, specifically a serum sodium level greater than 145 mEq/L. Sodium is an essential electrolyte that helps regulate water balance in and around your cells. It's crucial for many body functions, including the maintenance of blood pressure, regulation of nerve and muscle function, and regulation of fluid balance.

Hypernatremia typically results from a deficit of total body water relative to solute, which can be caused by decreased water intake, increased water loss, or a combination of both. Common causes include dehydration due to severe vomiting or diarrhea, excessive sweating, burns, kidney diseases, and the use of certain medications such as diuretics.

Symptoms of hypernatremia can range from mild to severe and may include thirst, muscle weakness, lethargy, irritability, confusion, seizures, and in extreme cases, coma or even death. Treatment typically involves correcting the underlying cause and gradually rehydrating the individual with intravenous fluids to restore normal sodium levels.

Urine is a physiological excretory product that is primarily composed of water, urea, and various ions (such as sodium, potassium, chloride, and others) that are the byproducts of protein metabolism. It also contains small amounts of other substances like uric acid, creatinine, ammonia, and various organic compounds. Urine is produced by the kidneys through a process called urination or micturition, where it is filtered from the blood and then stored in the bladder until it is excreted from the body through the urethra. The color, volume, and composition of urine can provide important diagnostic information about various medical conditions.

Collecting kidney tubules, also known as collecting ducts, are the final portion of the renal tubule in the nephron of the kidney. They collect filtrate from the distal convoluted tubules and glomeruli and are responsible for the reabsorption of water and electrolytes back into the bloodstream under the influence of antidiuretic hormone (ADH) and aldosterone. The collecting ducts then deliver the remaining filtrate to the ureter, which transports it to the bladder for storage until urination.

Osmolar concentration is a measure of the total number of solute particles (such as ions or molecules) dissolved in a solution per liter of solvent (usually water), which affects the osmotic pressure. It is expressed in units of osmoles per liter (osmol/L). Osmolarity and osmolality are related concepts, with osmolarity referring to the number of osmoles per unit volume of solution, typically measured in liters, while osmolality refers to the number of osmoles per kilogram of solvent. In clinical contexts, osmolar concentration is often used to describe the solute concentration of bodily fluids such as blood or urine.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

Aquaporin 1 (AQP1) is a type of aquaporin, which is a family of water channel proteins that facilitate the transport of water molecules across biological membranes. Aquaporin 1 is primarily responsible for facilitating water movement in various tissues, including the kidneys, red blood cells, and the brain.

In the kidneys, AQP1 is located in the proximal tubule and descending thin limb of the loop of Henle, where it helps to reabsorb water from the filtrate back into the bloodstream. In the red blood cells, AQP1 aids in the regulation of cell volume by allowing water to move in and out of the cells in response to osmotic changes. In the brain, AQP1 is found in the choroid plexus and cerebral endothelial cells, where it plays a role in the formation and circulation of cerebrospinal fluid.

Defects or mutations in the AQP1 gene can lead to various medical conditions, such as kidney disease, neurological disorders, and blood disorders.

Neurophysins are small protein molecules that are derived from the larger precursor protein, pro-neurophysin. They are synthesized in the hypothalamus of the brain and are stored in and released from neurosecretory granules, along with neurohypophysial hormones such as oxytocin and vasopressin.

Neurophysins serve as carrier proteins for these hormones, helping to stabilize them and facilitate their transport and release into the bloodstream. There are two main types of neurophysins, neurophysin I and neurophysin II, which are associated with oxytocin and vasopressin, respectively.

Neurophysins have been studied for their potential role in various physiological processes, including water balance, social behavior, and reproductive functions. However, their precise mechanisms of action and functional significance are still not fully understood.

Potassium deficiency, also known as hypokalemia, is a condition characterized by low levels of potassium (

Diuresis is a medical term that refers to an increased production of urine by the kidneys. It can occur as a result of various factors, including certain medications, medical conditions, or as a response to a physiological need, such as in the case of dehydration. Diuretics are a class of drugs that promote diuresis and are often used to treat conditions such as high blood pressure, heart failure, and edema.

Diuresis can be classified into several types based on its underlying cause or mechanism, including:

1. Osmotic diuresis: This occurs when the kidneys excrete large amounts of urine in response to a high concentration of solutes (such as glucose) in the tubular fluid. The high osmolarity of the tubular fluid causes water to be drawn out of the bloodstream and into the urine, leading to an increase in urine output.
2. Forced diuresis: This is a medical procedure in which large amounts of intravenous fluids are administered to promote diuresis. It is used in certain clinical situations, such as to enhance the excretion of toxic substances or to prevent kidney damage.
3. Natriuretic diuresis: This occurs when the kidneys excrete large amounts of sodium and water in response to the release of natriuretic peptides, which are hormones that regulate sodium balance and blood pressure.
4. Aquaresis: This is a type of diuresis that occurs in response to the ingestion of large amounts of water, leading to dilute urine production.
5. Pathological diuresis: This refers to increased urine production due to underlying medical conditions such as diabetes insipidus or pyelonephritis.

It is important to note that excessive diuresis can lead to dehydration and electrolyte imbalances, so it should be monitored carefully in clinical settings.

Specific gravity is a term used in medicine, particularly in the context of urinalysis and other bodily fluid analysis. It refers to the ratio of the density (mass of a substance per unit volume) of a sample to the density of a reference substance, usually water. At body temperature, this is expressed as:

Specific gravity = Density of sample / Density of water at 37 degrees Celsius

In urinalysis, specific gravity is used to help evaluate renal function and hydration status. It can indicate whether the kidneys are adequately concentrating or diluting the urine. A lower specific gravity (closer to 1) may suggest overhydration or dilute urine, while a higher specific gravity (greater than 1) could indicate dehydration or concentrated urine. However, specific gravity should be interpreted in conjunction with other urinalysis findings and clinical context for accurate assessment.

Hydronephrosis is a medical condition characterized by the swelling of one or both kidneys due to the accumulation of urine. This occurs when the flow of urine from the kidney to the bladder is obstructed, causing urine to back up into the kidney. The obstruction can be caused by various factors such as kidney stones, tumors, or congenital abnormalities. If left untreated, hydronephrosis can lead to serious complications including kidney damage and infection. It is typically diagnosed through imaging tests such as ultrasound, CT scan, or MRI.

Primary polydipsia may lead to polyuria. Polyuria is usually viewed as a symptom or sign of another disorder (not a disease by ... Polyuria (/ˌpɒliˈjʊəriə/) is excessive or an abnormally large production or passage of urine (greater than 2.5 L or 3 L over 24 ... Polyuria may also be due to various chemical substances, such as diuretics, caffeine, and ethanol. It may also occur after ... Polyuria often appears in conjunction with polydipsia (increased thirst), though it is possible to have one without the other, ...
Less than 1% of patients have the following side effects: burning or itching of penis of sexual partner; polyuria; vulvar ...
Polyuria and tuberculosis. Proceedings of the Pathological Society of Philadelphia, 1893, 16: 282-284. Archives of Pediatrics, ...
Excessive/submissive urination (polyuria); urinating more frequently than expected or under conditions where it would not be ...
Polyuria Having to urinate often; a common sign of diabetes. Postprandial blood glucose Blood taken 1-2 hours after eating to ...
Polyuria is resistant to vasopressin. When other organ systems are affected, symptoms can include situs inversus, heart ... They include polyuria, polydipsia, weakness, and fatigue.Anemia, growth retardation, no hypertension. Proteinuria and hematuria ... Inability to conserve sodium because of defect of tubules leading to polyuria and polydipsia. Anemia is attributed to a ...
It is recommended that it be cautiously used in instances of perioperative polyuria, sensitivity to the drug, asthma, seizures ... ISBN 978-1-4557-5942-2. Donaldson D (1994). "Polyuria and Disorders of Thirst". In Williams DL, Marks V (eds.). Scientific ... polyuria (excess urine production), and polydipsia (thirst). Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH) ...
Miller, Wilbur (1936). "Psychogenic Factors in the Polyuria of Schizophrenia". Journal of Nervous and Mental Disease. Barlow, ... "A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria". The ...
In addition, polyuria and heart disease occurred. On 14 April 1968, he suffered a heart attack while sitting with his son AKM ...
Hyposecretion of insulin results in diabetes mellitus; cardinal signs are polyuria, polydipsia, and polyphagia. Clarke, I. J. ( ...
Based on information recorded in the diary, a physician can classify the patient as having global polyuria, nocturnal polyuria ... With the 24-hour urine production within normal limits, nocturnal polyuria can be translated to having a nocturnal polyuria ... Global polyuria is the continuous overproduction of urine that is not only limited to sleep hours. Global polyuria occurs in ... Polyuria is usually viewed as a symptom or sign of another disorder (not a disease by itself), but it can be classed as a ...
Polyuria is a condition of excessive urine production (> 2.5 L/day). Conditions involving low output of urine are oliguria (< ...
Polyuria and/or polydipsia (nephrogenic diabetes insipidus) 5. Ataxia, poor coordination, imbalance 6. Mild spasticity ( ...
This condition has only polyuria in common with diabetes. Although not mutually exclusive, with most typical cases, the name ... Specifically, other more common causes of polyuria and polydipsia are ruled out. Common rule outs include: diabetes mellitus, ... A better name might be "hypothalamic-neurohypophyseal ADH deficiency". Increased thirst, polyuria and dehydration with ...
It is classically associated with polyuria, polydipsia, and polyphagia; weight loss, lethargy, and diaper candidiasis may also ...
Smith DF (April 1976). "Lithium orotate, carbonate and chloride: pharmacokinetics, polyuria in rats". British Journal of ...
Polyuria is a condition of excessive production of urine (> 2.5 L/day), oliguria when < 400 mL are produced, and anuria being ...
Polyuria and polydipsia, diarrhea, and shivering are occasionally reported. Hypoglycemia can also be present, and initially may ...
Polyuria Nocturnal enuresis "Frequent or urgent urination: MedlinePlus Medical Encyclopedia". medlineplus.gov. 5 December 2017 ... It is often, though not necessarily, associated with urinary incontinence and polyuria (large total volume of urine). However, ...
merck.com Polyuria: A Merck Manual of Patient Symptoms podcast. Last full review/revision September 2009 by Seyed-Ali Sadjadi, ... Age is a risk factor that increases both the severity and prevalence of UI Polyuria (excessive urine production) of which, in ... Polyuria generally causes urinary urgency and frequency, but does not necessarily lead to incontinence. Neurogenic disorders ... Non-urologic causes may include infection, medication or drugs, psychological factors, polyuria, hydrocephalus, stool impaction ...
The symptoms may relate to fluid loss and polyuria, but the course may also be insidious. Diabetic animals are more prone to ... Classic symptoms include thirst, polyuria, weight loss, and blurred vision. If left untreated, the disease can lead to various ... The classic symptoms of untreated diabetes are polyuria, thirst, and weight loss. Several other non-specific signs and symptoms ... polyuria) and increased fluid loss. Lost blood volume is replaced osmotically from water in body cells and other body ...
... (/ˌdaɪjʊˈriːsɪs/) is the excretion of urine, especially when excessive (polyuria). The term collectively denotes the ... polyuria, diarrhea, heat exhaustion, starting or changing doses of diuretics, and others) can require management of ... Osmotic diuresis results in dehydration from polyuria and the classic polydipsia (excessive thirst) associated with DM.[ ...
... polyuria, increased appetite (polyphagia) and irritability). Musculoskeletal system (any bone or joint pain accompanied by ...
With increased thirst, the person now experiences a polydipsia and polyuria cycle. Hereditary forms of diabetes insipidus ... and traditionally have administered thiazide diuretics for lithium-induced polyuria and nephrogenic diabetes insipidus. However ...
Livestock ingesting large amounts can experience weight loss, hyperbilirubinemia, photosensitization, and polyuria. The plant's ...
Observable symptoms may develop such as polydipsia, polyuria, extreme fatigue, or constipation. In certain outdoor environments ...
Polyuria will continue as long as the patient is able to drink. If the patient is unable to drink and is still unable to ... The two diseases were named (in ancient times) for the fact that one features polyuria in which the urine tastes sweet, whereas ... The major causes of acquired nephrogenic diabetes insipidus that produce clinical symptoms (e.g., polyuria) in the adult are ... diabetes mellitus causes polyuria via osmotic diuresis, due to the high blood sugar leaking into the urine, taking excess water ...
Patients may also present with a fever, nausea, vomiting, dysuria and polyuria. If untreated, the chronic infections can ...
This gives rise to diabetes insipidus, a disorder characterized by polyuria and polydipsia. Other adverse effects of lithium ...
The combination of polydipsia and (nocturnal) polyuria is also seen in (primary) hyperaldosteronism (which often goes with ... As it is often accompanied by polyuria (excessive urination) and low sodium levels. Investigations directed at diagnosing ...
Primary polydipsia may lead to polyuria. Polyuria is usually viewed as a symptom or sign of another disorder (not a disease by ... Polyuria (/ˌpɒliˈjʊəriə/) is excessive or an abnormally large production or passage of urine (greater than 2.5 L or 3 L over 24 ... Polyuria may also be due to various chemical substances, such as diuretics, caffeine, and ethanol. It may also occur after ... Polyuria often appears in conjunction with polydipsia (increased thirst), though it is possible to have one without the other, ...
Articles similar to: nocturnal polyuria. As Waking Up Multiple Times a Night to Urinate Can Lead to Memory Deficits, Obesity, ... known as nocturnal polyuria. The poll shows that while nocturia may affect more than a third of U.S. adults, 64 percent of ... nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria ( ...
Polyuria - Frequent Urination Polyuria is a condition where the body urinates more than usual and … Continue reading Polyuria ... www.diabetes.co.uk/symptoms/polyuria.html/embed/#?secret=oggUF6FWJp width=600 height=400 title=“Polyuria – ... blockquote class=wp-embedded-content data-secret=oggUF6FWJp,,a href=https://www.diabetes.co.uk/symptoms/polyuria.html, ... Polyuria – Frequent Urination,/a,,/blockquote,,iframe sandbox=allow-scripts security=restricted src=https:// ...
This stands for polyuria and polydipsia. Common causes include things like... Learn More ...
Study findings suggest clinicians manage nocturnal polyuria by treating factors affecting urine production rather than bladder ... The Epidemiology of Nocturnal Polyuria (EpiNP) study, which was published in the Journal of Urology, demonstrated that NP is ... Investigators used 2 definitions of NP: a nocturnal polyuria index greater than 33% (NPI33) and a rate of nocturnal urine ... Differences in the prevalence of nocturnal polyuria in the US by definition: results from the epidemiology of nocturnal ...
Ill have spells of polyuria, usually following an adrenaline rush and it will go on for about two or three hours and even if I ... Dr Raj at Vanderbilt told me I had Chronic Fatigue Syndrome - and one of the symptoms of CFS is polyuria.... ...
Approach to the Patient with Polyuria and Polydipsia. 1. Polyuria and polydipsia (PU/PD) refer to excessive water consumption ... Approach to the Patient with Polyuria and Polydipsia World Small Animal Veterinary Association World Congress Proceedings, 2015 ...
... - [päl΄ē yoor′ē ə] n. [ModL: see POLY & URIA] excessive urination, as in some diseases polyuric adj … English World ... Polyuria - In medicine, polyuria is a condition characterized by the passage of large volumes of urine (at least 2.5 L over 24 ... Polyuria - The passage of an abnormally large amount of urine. Someone with polyuria passes too much urine and so may have ... Polyuria - Pol y*u ri*a, n. [NL. See {Poly }, and {Urine}.] (Med.) A persistently excessive flow of watery urine, with low ...
Urinating frequently (polyuria). Heal Your Self AURELIS guided meditations are scientifically backed. Start Your Free ...
Polyuria has generally been defined as a urine output exceeding 3 L/day in adults and 2 L/m2 in children. ...
Polyuria is defined as the passage of excessive quantities of urine. Pollakauria is defined as urinary frequency; in other ... In other words, polyuria begats polyuria. Bouts of polyuria might explain why some people have a variable sensitivity to ... Polyuria is arbitrarily defined as the passage of more than 30 mL of urine per kilogram of body weight per day. For the average ... Calculations showed that polyuria, at this body weight, would be a urine output greater than 1.1 L daily. Thus, she was ...
... my 10-year-old niece presented with complaints of polyuria, polydipsia, intermittent abdominal pain, and poor growth. She was ... One hallmark of polyuria is the diluted nature of the urine produced-its composed of more water than urine. Some treatments ... Polyuria that cannot be corrected by treating the underlying cause is often treated with one of several medications that come ... awanish The most effective treatment for polyuria is aimed at the underlying cause. For example, lithium-induced nephrogenic ...
Polyuria - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical Professional ... The most common cause of polyuria (see table Some Causes of Polyuria Some Causes of Polyuria ) in adults and children is ... Clinical evaluation may suggest a cause (see table Some Causes of Polyuria Some Causes of Polyuria ), but testing is usually ... History of present illness should include the amounts of fluid consumed and voided to distinguish between polyuria Polyuria ...
Why does polyuria occur? The most prevalent causes of polyuria are type 1 and type 2 diabetes. Medications, coffee, alcohol, ... Why Do Diabetics Have Polyuria - RELATED QUESTIONS. What amount of blood sugar induces polyuria?. Two subgroups of patients ... Why does diabetes result in polydipsia and polyuria? Polydipsia in persons with diabetes is caused by elevated blood glucose ... The three polys are the primary symptoms of diabetes: polyuria, polydipsia, and polyphagia. Individuals at high risk for ...
Discover the differences between Polyuria and Epoxy Coatings with Utah Epoxy Company. Learn about the pros and cons, material ... What are Polyuria Coatings?. Polyuria coatings are a type of concrete coating that is made from a blend of polyurethane and ... Polyuria coatings are made from a blend of polyurethane and resins, while epoxy coatings are made from a mixture of resin and ... In conclusion, both polyuria and epoxy coatings have their pros and cons, and the choice between the two will depend on your ...
Urinary Incontinence and Polyuria Nelson Pediatric Symptom-Based Diagnosis 1 January 2017:824-830.e1. Date. 01/01/2017. DOI. ...
Polyuria is occasionally observed after general anesthesia with sevoflurane. Usually the onset of polyuria is abrupt and ... Transient Polyuria during SevofluraneAnesthesia : A report of two cases. Shin Young Lee, Hye Young Kim, Hye Won Shin, Hye Won ... The authors came across with two cases of polyuria during general anesthesia with sevoflurane which occurred so early around ...
Find out how high solute ingestion and excessive fluid intake contributed to this case of polyuria. ... Polyuria can be incapacitating for patients by disrupting their daily activities and sleep cycle. Polyuria can result in volume ... Polyuria, defined as daily urine output in excess of 3.0 to 3.5 L/d, can occur due to solute or water diuresis. Solute-induced ... Polyuria is an important clinical condition characterized by urine output in excess of 3.0 to 3.5 L/d and low urine osmolality ...
Genetic deletion of connexin 37 causes polyuria and polydipsia.. Genetic deletion of connexin 37 causes polyuria and polydipsia ... 20Genetic deletion of connexin 37 causes polyuria and polydipsia.. ...
Nocturnal polyuria. Studies reveal nocturnal polyuria in some but not all children with enuresis. Although nocturnal polyuria ... Nocturnal polyuria in children with enuresis may be multifactorial. Possible causes include the following:. * Increased fluid ... Although nocturnal polyuria is presumed to be the cause of the bedwetting, a disorder of arousal is also likely to be present ... Nocturnal polyuria does not explain why children with enuresis do not wake up to the sensation of a full or contracting bladder ...
Polyuria. R39.1. Other difficulties with micturition. R39.9. Unspecified symptoms and signs involving the genitourinary system ...
Renal manifestations include polyuria, kidney stones, hypercalciuria, and, rarely, nephrocalcinosis.. Gastrointestinal ...
Polyuria is a fairly common symptom. People often notice the problem when they have to get up during the night to use the ...
The majority of diabetic dogs appear to have a form of type 1 diabetes analogous to the latent autoimmune diabetes of adults (LADA) in humans. Evidence of acute or chronic pancreatitis occurs in about 40% of diabetic dogs. Blindness caused by cataract formation eventually occurs in the majority of d …
Investigating polyuria BMJ 2013; 347 :f6772 (Published 02 December 2013) *PDF. *Permission ...
Urinary System: polyuria. Nervous System: dizziness, headache, paresthesia, tremor. Vision: visual disturbance ...
Polyuria. *Primary Pulmonary Hypertension. *Prinzmetal Angina. *Pulmonary Edema. *Pulmonary Hypertension. *Pulmonary Valve ...
Excessive urination (polyuria). *Kidney stone. *Intermenstrual bleeding. *Excessive menstrual bleeding (menorrhagia). *White ...
Dr. Shakti Matta, MD is a pediatrics specialist in Kennewick, WA and has over 34 years of experience in the medical field. He graduated from Maulana Azad Med Coll- Univ Of Delhi- New Delhi- Delhi- India|Maulana Azad Med Coll-Delhi U in 1988. He is affiliated with medical facilities Trios Womens and Childrens Hospital and Kadlec Regional Medical Center. His office accepts new patients.
Polyuria. 0.1%. 0.6%. * n Is the total number of patients exposed to the dose at any time during the study.. ...
  • Polyuria often appears in conjunction with polydipsia (increased thirst), though it is possible to have one without the other, and the latter may be a cause or an effect. (wikipedia.org)
  • Primary polydipsia may lead to polyuria. (wikipedia.org)
  • This stands for polyuria and polydipsia. (friendshiphospital.com)
  • 1. Polyuria and polydipsia (PU/PD) refer to excessive water consumption and urine production, respectively. (vin.com)
  • Hello, my 10-year-old niece presented with complaints of polyuria, polydipsia, intermittent abdominal pain, and poor growth. (reanfoundation.org)
  • Polyuria and polydipsia. (msdmanuals.com)
  • Why does diabetes result in polydipsia and polyuria? (welivingwell.com)
  • The three polys are the primary symptoms of diabetes: polyuria, polydipsia, and polyphagia. (welivingwell.com)
  • [ 3 ] The differential diagnosis of polyuria includes central diabetes insipidus, congenital or acquired nephrogenic diabetes insipidus, psychogenic polydipsia, high protein or hyperglycemic osmotic diuresis, salt-wasting nephropathies, mixed polyuria due to excess solute and water intake, and postobstructive diuresis following recovery from urinary obstruction. (medscape.com)
  • We describe a case of a woman who presented with concerns regarding polyuria and polydipsia of more than one year duration. (medscape.com)
  • Genetic deletion of connexin 37 causes polyuria and polydipsia. (potassium-bloodpressure.org)
  • https://potassium-bloodpressure.org/wp-content/uploads/2020/07/Potassium-logo-450.png 0 0 Boyoung Kim https://potassium-bloodpressure.org/wp-content/uploads/2020/07/Potassium-logo-450.png Boyoung Kim 2021-02-01 04:59:06 2021-03-08 01:12:20 Genetic deletion of connexin 37 causes polyuria and polydipsia. (potassium-bloodpressure.org)
  • Classic symptoms (polydipsia, polyuria and weight loss) were present in around half of the participants but were not more prevalent in those with diabetes. (who.int)
  • Symptoms of polyuria, polydipsia and unexplained weight loss with i. fasting glucose = 7.0mmol/l or ii. (who.int)
  • For example, lithium-induced nephrogenic diabetes insipidus could potentially be treated by discontinuing the lithium.7 Polyuria caused by diabetes mellitus is likely to be improved once the patient's blood glucose levels are under control. (reanfoundation.org)
  • Investigators used 2 definitions of NP: a nocturnal polyuria index greater than 33% (NPI33) and a rate of nocturnal urine production greater than 90 mL/h (NUP90). (renalandurologynews.com)
  • Nocturnal polyuria was defined as a nocturnal urine volume per 24-hour production of greater than 0.35 (the nocturnal polyuria index). (inbodybwa.com)
  • Dr Raj at Vanderbilt told me I had Chronic Fatigue Syndrome - and one of the symptoms of CFS is polyuria. (dinet.org)
  • Someone with polyuria passes too much urine and so may have frequency, the need to urinate frequently. (en-academic.com)
  • citation needed] The most common cause of polyuria in both adults and children is uncontrolled diabetes mellitus, which causes osmotic diuresis, when glucose levels are so high that glucose is excreted in the urine. (wikipedia.org)
  • Polyuria, defined as daily urine output in excess of 3.0 to 3.5 L/d, can occur due to solute or water diuresis. (medscape.com)
  • We describe a case of polyuria due to high solute ingestion and excessive water intake leading to a mixed picture of solute and water diuresis. (medscape.com)
  • According to NICE, desmopressin can be considered for nocturnal polyuria, which can be caused by diabetes mellitus, if other medical treatments have failed. (wikipedia.org)
  • The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night). (simonfoundation.org)
  • Nocturia has many contributing causes, but in most cases, it is caused by the kidneys producing too much urine at night, known as nocturnal polyuria. (simonfoundation.org)
  • Nocturia, also called nocturnal polyuria, might not be dangerous by itself, but it may be caused by an underlying medical condition that needs to be treated. (onteenstoday.com)
  • The FDA has approved Noctiva (desmopressin acetate) for adults with nocturnal polyuria. (onteenstoday.com)
  • Clinicians are praising a recent study that provides insight into the pathophysiology of nocturnal polyuria (NP). (renalandurologynews.com)
  • Accoding to modern pathophysiology, lkshumeha includes the conditions of glycosuria with mild to moderate polyuria. (who.int)
  • I will say, however, that it is important to recognize that the greater the polyuria, the greater the washout of the solutes in the medulla of the kidney, and is the less the concentrating ability of the kidney in response to vasopressin. (pituitaryworldnews.org)
  • In conclusion, in polyuria induced by hyperglycemia, the urine glucose concentration should be between 300 and 400 mmol/L if renal function is normal. (welivingwell.com)
  • The stage of impaired glucose tolerance, which shows polyuria in spite of the absence of Glycosuria, can be included in Udakameha. (who.int)
  • Mild oliguria (380 mL/24 h) and polyuria rodents. (cdc.gov)
  • This leads in an increase in urine output, urinary frequency, and urgency, which is known as polyuria. (welivingwell.com)
  • Solute-induced polyuria can be seen in hospitalized patients after a high solute load from exogenous protein administration or following relief of urinary obstruction. (medscape.com)
  • Determination of the daily excreted urinary osmoles may yield important clues to the cause of polyuria and should be included in the routine workup of polyuria. (medscape.com)
  • Polyuria can result in volume depletion, rapid fluctuations in serum sodium levels, and distension of the renal outflow tract due to high urinary output volume. (medscape.com)
  • A recent study provides clues to managing nocturnal polyuria by emphasizing factors influencing urine production instead of bladder capacity. (renalandurologynews.com)
  • The medication curbs urine production, thereby allowing people with nocturnal polyuria to sleep. (onteenstoday.com)
  • Polyuria (/ˌpɒliˈjʊəriə/) is excessive or an abnormally large production or passage of urine (greater than 2.5 L or 3 L over 24 hours in adults). (wikipedia.org)
  • Polyuria - The passage of an abnormally large amount of urine. (en-academic.com)
  • polyuria - [ˌpɒlɪ jʊərɪə] noun Medicine production of abnormally large volumes of dilute urine. (en-academic.com)
  • Restriction of the daily solute load and water intake resulted in complete resolution of polyuria. (medscape.com)
  • One study from 2008 lays out a hypothesis that hyperglycaemic and osmotic polyuria play roles ultimately in diabetic nephropathy. (wikipedia.org)
  • The diagnostic principles used in this teaching case illustrate the approach to the evaluation of polyuria in an outpatient setting. (medscape.com)
  • Polyuria - In medicine, polyuria is a condition characterized by the passage of large volumes of urine (at least 2.5 L over 24 hours in adults). (en-academic.com)
  • Polyuria is defined as the passage of excessive quantities of urine. (pituitaryworldnews.org)
  • Polyuria is arbitrarily defined as the passage of more than 30 mL of urine per kilogram of body weight per day. (pituitaryworldnews.org)
  • Polyuria coatings are also highly resistant to chemicals, making them ideal for industrial and commercial settings. (utepoxy.com)
  • In conclusion, both polyuria and epoxy coatings have their pros and cons, and the choice between the two will depend on your specific needs and requirements. (utepoxy.com)
  • Some treatments for polyuria include giving a type of diuretic, which usually increases urine output because it improves the way urine is processed in the kidneys. (reanfoundation.org)
  • Among the possible tests to diagnose polyuria are: Urine test FBC Blood test Pituitary function test Depending on the cause of the polyuria, the adequate treatment should be afforded. (wikipedia.org)
  • The Epidemiology of Nocturnal Polyuria (EpiNP) study, which was published in the Journal of Urology , demonstrated that NP is highly prevalent in both sexes in the United States, but it is much more common in women. (renalandurologynews.com)
  • One hallmark of polyuria is the diluted nature of the urine produced-it's composed of more water than urine. (reanfoundation.org)
  • Polyuria coatings are a type of concrete coating that is made from a blend of polyurethane and resins. (utepoxy.com)
  • As soon as his polyuria abated he slept 18 hours….awakened only by the dDAVP having worn off! (pituitaryworldnews.org)
  • Polyuria has generally been defined as a urine output exceeding 3 L/day in adults and 2 L/m2 in children. (mdpathyqa.com)
  • Calculations showed that polyuria, at this body weight, would be a urine output greater than 1.1 L daily. (pituitaryworldnews.org)
  • We investigated the relationship between nocturnal polyuria and the variation of body fluid distribution during the daytime using bioelectric impedance analysis. (inbodybwa.com)
  • The authors came across with two cases of polyuria during general anesthesia with sevoflurane which occurred so early around one hour after induction of anesthesia. (anesth-pain-med.org)
  • For the average-sized adult, of 70 kg, greater than 2.1 L per day wo uld be considered polyuria. (pituitaryworldnews.org)
  • Polyuria coatings are typically used in industrial and commercial settings where high levels of durability and resistance are required. (utepoxy.com)